Videos

Dr Blauvelt on the Comparative Durability and Safety of Biologics

07/20/2020

In this video, Andrew Blauvelt, MD, MBA, details the differences in maintenance of response and safety of various biologic therapies for the treatment of plaque psoriasis.

Dr Blauvelt is the president of the Oregon Medical Research Center in Portland, OR. He has previously served as an investigator on various trials, including several clinical studies on the efficacy of risankizumab, an IL-23 inhibitor for the treatment of psoriasis.

To read more about the comparative efficacy of risankizumab and the latest results from Dr Blauvelt, visit our Dermatology Advances resource.

Current Issue

August 2024

Volume 32

Issue 5

Current Issue

Issue Archive

Popular Articles

Contemplating the Comedone

09/04/2008

M ost agree that it begins silently and asymptomatically as the microcomedone — a medically innocuous series of cellular events lead to this precursor lesion that once clinically expressed, can irrevocably change lives and fuel multi-million...

M ost agree that it begins...

09/04/2008

The Dermatologist

Videos

Recent FDA Approval: Updates in Dupilumab

07/11/2022

In this video, Mercedes Gonzalez, MD, discusses the recent FDA approval for dupilumab to treat infants and young children with atopic dermatitis.

In this video, Mercedes...

07/11/2022

The Dermatologist

Coding and Billing

Differentiating Between Referrals and Consultations

09/04/2008

Q: I know you’ve written about consultations before. However, I still find it very confusing as to how to differentiate between a consultation and a referral. I prepared the chart (below) in an attempt to compare a referral with a...

Q: I know you’ve written about...

09/04/2008

The Dermatologist

Dr Cathal O'Connor on Burden of Treatment in Patients With Atopic Dermatitis

Videos

Burden of Treatment in Patients With Atopic Dermatitis

08/18/2022

In this interview, Cathal O’Connor, MD, addresses the burden of treatment in adult patients with atopic dermatitis, including its effect on the decision-making process for dermatologists and patients’ quality of life.

In this interview, Cathal...

08/18/2022

The Dermatologist

Allergen Focus

Focus on T.R.U.E. Test Allergen #12: Cobalt

09/04/2008

T he thin-layer rapid use epicutaneous (T.R.U.E.) test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...

T he thin-layer rapid use...

09/04/2008

The Dermatologist

The Dermatologist Newsletter

Latest Quizzes and Trivia

Quiz

QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

08/10/2024

Riya Gandhi , MA;

What strategies did Dr Merola emphasize for atopic dermatitis?

What strategies did Dr Merola...

08/10/2024

The Dermatologist

contact dermtitis + Neck + Eczema + rash

Quiz

QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing

07/14/2024

What is a common challenge for patients during the patch testing week?

What is a common challenge for...

07/14/2024

The Dermatologist

Quiz

Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis

05/30/2024

Riya Gandhi, MA, Associate Editor

According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?

According to a recent interview...

05/30/2024

The Dermatologist

Quiz

Quiz: Atopic Dermatitis Spotlight

05/06/2024

Riya Gandhi, MA, Associate Editor

Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?

Which class of medications...

05/06/2024

The Dermatologist

Quiz

True or False: Basal Cell Carcinoma on Vermilion Lip

05/01/2024

Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?

Is basal cell carcinoma on the...

05/01/2024

The Dermatologist

Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee

Quiz

Quiz: Navigating New Therapies in Atopic Dermatitis

04/10/2024

Riya Gandhi, MA, Associate Editor

In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?

In a recent interview, Dr...

04/10/2024

The Dermatologist

Quiz

Trivia: Atopic Dermatitis Patients With Alopecia Areata

02/28/2024

Riya Gandhi, MA, Associate Editor

02/28/2024

The Dermatologist

Quiz

Trivia: Itch Cycle and OTC Products

12/27/2023

The Dermatologist

Quiz

12/20/2023

Jessica Garlewicz, Digital Managing Editor

When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?

When treating mild to moderate...

12/20/2023

The Dermatologist

Quiz

Dupilumab Mechanism of Action

11/07/2023

Jessica Garlewicz, Digital Managing Editor

According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?

According to a recent interview...

11/07/2023

The Dermatologist

Dr Blauvelt on the Comparative Durability and Safety of Biologics

Current Issue

Popular Articles

Subscribe

Latest Quizzes and Trivia

Specialties

Events

Year Round Education

HMP Global Products